Extended spectrum β-lactamases (ESBL) - An emerging threat to clinical therapeutics

Indian Journal of Medical Microbiology

Volumn 22, Issue 2, 2004, Pages 75-80

  Chaudhary, U ^a   Aggarwal, R ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Broad spectrum cephalosporins; Clavulanic acid; Klebsiella pneumoniae; lactams

Indexed keywords

AMIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFMETAZOLE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CEPHAMYCIN; CLAVULANIC ACID; ERTAPENEM; FROPENEM; IMIPENEM; LATAMOXEF; MEROPENEM; MONOBACTAM DERIVATIVE; PENICILLINASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE; SULBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CHEMICAL BOND; CLASSIFICATION; CONTINUING EDUCATION; DRUG HYDROLYSIS; DRUG USE; ENTEROBACTER CLOACAE; ENZYME ANALYSIS; ENZYME INACTIVATION; ENZYME ISOLATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SYNTHESIS; ESCHERICHIA COLI; HEALTH CARE POLICY; HUMAN; INOCULATION; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; MEDICAL DECISION MAKING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; REVERTANT; REVIEW; RISK FACTOR; SALMONELLA TYPHIMURIUM; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; WESTERN EUROPE;

EID: 2442558350     PISSN: 02550857     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Ayyagari A, Bhargava A. β-lactamases and their clinical significance ( A mini review). Hosp Today 2001;6(10):1-6.
2. Nathisuwan S, Burgess DS, Lewis II JS. ESβLs : Epidemiology, Detection and Treatment. Pharmacotherapy 2001;21(8): 920-928.
3. Sirot D. Extended - spectrum plasmid - mediated β-lactmases. J Antimicrob Chemother 1995;36(Suppl A):19-34.
4. Medeiros AA. Evolution and dissemination of β-lactamases acclerated by generations of β-lactam antibiotics. Clin Infect Dis 1997;24(Suppl 1):S19-45.
5. Nordmann P. Trends in β-lactam resistance among Enterobacteriaceae. Clin Infect Dis 1998;27(Suppl 1): S100-S1006.
6. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-1233.
7. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC Jr, editors. Antimicrobial suceptibility testing. In : Color Atlas And Textbook of Diagnostic Microbiology. 5th ed. (Lippincott, Philadelphia) 1997; 785-856.
8. Jacoby GA, Medeiros AA. More extended spectrum β-lactamases. Antimicrob Agents Chemother 1991;35:1697-1704.
9. Coudron PE, Moland ES, Sanders CC. Occurrence and detection of ESβL in members of the family Enterobacteriacieae at a Veterans Medical Center: Seek and you may find. J Clin Microbiol 1997;35:2593-2597.
10. Revathi G, Singh S. Detection of Expanded spectrum cephalosporin resistance due to inducible lactamases in hospital isolates. Indian J Med Microbiol 1997;15(3):113-115.
11. Emery CL, Weymouth LA. Detection and clinical significance of ESβLs in a tertiary - care medical center. J Clin Microbiol 1997;35:2061-2067.
12. Jarlier V, Nicolas MH, Fournier G, Philippon A. ESβLs conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-878.
13. Thomson KS, Sanders CC. Detection of ESβLs in members of the family Enterobacteriaceae. Comparison of the double disk and three-dimensional test. Antimicrob Agents Chemother 1992;36:1877-1882.
14. Ho PL, Chow KH, Yuen KY, Ng WS, Chau PY. Comparison of novel, inhibitor potentiated disc diffusion test with other methods for the detection of ESβL in E.coli and K. pneumoniae. J Antimicrob Chemther 1998;42:49-54.
15. Sanders CC, Barry AL, Washington JA, Shubert C, Moland ES, Traczewski MM, Knapp C, Mulder R. Detection of ESβL producing members of the family Enterobacteriaceae with the Vitek ESβL test. J Clin Microbiol 1996;34:2997-3001.
16. Vercauteren E, Descheemaeker P, Leven M, Sanders CC, Goossens H. Comparison of screening methods for detection of ESβL and their prevalence among blood isolates of E.coli and Klebsiella spp. in a Belgian teaching hospital. J Clin Microbiol 1997;35:2191-2197.
17. Piroth L, Aube H, Doise JM, Martin MV. Spread of ESβL - producing K. pneumoniae. Are β-lactamase inhibitors of therapeutic value? Clin Infect Dis 1998;27:76-80.
18. Sirot J, Chanal C, Petil A, Sirot D, Labia R, Gerbaud G. K. pneumoniae and other Enterobacteriaceae producing novel plasmid mediated β-lactamases markedly active against third-generation cephalosporin: epidemiologic studies. Rev Infect Dis 1988;10:850-859.
19. Ananthkrishnan AN, Kanungo R, Kumar A, Badrinath S. Detection of ESβL producers among surgical wound infections and burns patients in JIPMER. Indian J Med Microbiol 2000;18(4):160-165.
20. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of ESβL producing gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002;115:153-157.